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My academic career had its roots in my residency. I had be-
gun my residency at Stanford in what was then (1967)
called general radiology, alternating every 6 months be-
tween diagnostic radiology and therapy for 2 years, before
committingafinal2yearstooneortheother.Butafteronly
2 days of therapy training, I was hooked and requested not
torotate,butsimplyconcentrateonthetreatmentsideofra-
diology. When asked why, I simply responded that I didn’t
want to spend a month of my life doing nothing but barium
enemas!
It’s almost impossible to convey the thrill, excitement,
and stimulation of oncology training at Stanford in the
1960s. Typically I would sing, whistle, or hum driving to
workinanticipationofthewondersoftheday.Youlearned
a whole new way to think when you were around people
such as Henry Kaplan, Saul Rosenberg, Mal Bagshaw, and
therestofafabulouscollectionofjuniorfaculty.Youhadto
learntothinkandreasonlogicallyifyouweregoingtokeep
up with them. You needed data as evidence for your think-
ingbutyoualsohadtobeabletointerpretthedata.Always,
they treated residents with respect and never did they talk
down to trainees or students.
Kaplan, in particular, was an astounding intellect. A
large, imposing, restless man with an enormous grasp of
scienceandadeep,resonatingvoicethatheoftenclearedin
analmosttheatricalmanner,healwayssawtheglassashalf
empty. He was arguably the best pure thinker in oncology,
but also a man of enormous interests in literature, art, and
music.
Rosenbergwasnoslouchasathinkereither.Hewasthe
quintessential physician by any and all parameters: com-
passionate,knowledgeable,andempathetic.HeandKaplan
ran a joint lymphoma clinic that was generally staffed only
by the senior residents from medical oncology and radio-
therapy. Nonetheless, I worked voluntarily each week from
my first year in the Monday afternoon clinic (which rarely
finished before 6 p.m. and usually much later) because I
wanted as much exposure to the two of them as I could get.
And boy, it was worth it! Beginning from different posi-
tions they would usually come to the same conclusion on
really difficult patients in follow-up. What was really im-
pressive was the way each of them would reason the case.
To me, it was all high drama and I loved it. Because I re-
spected both of them so much, I never came away from this
early experience in a conjoint clinic with any sense of an
adversarial relationship between competing modalities but
rather a true partnership, which I still treasure today. In
those days in that conjoint clinic it would not have been un-
usualfortheradiotherapytraineetopresentapatienttreated
by radiation alone to Rosenberg, or the medical oncology
trainee to present someone treated with chemotherapy
alone to Kaplan. This crossfertilization only confirmed the
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The Oncologist 2010;15:388–389 www.TheOncologist.comtrue duality of this partnership. Moreover, although many
peopleoutsidethedepartmentviewedmeas“LittleHenry,”
I always thought of myself as more trying to emulate Saul
than Henry.
There were other conjoint clinics at Stanford in the
1960s, which were less satisfying but still good. Bagshaw,
inparticular,wasexceptionalatteachingusaboutlatemor-
bidities of radiation treatment. As the Head of the Treat-
ment Division, he had a policy of requiring his written
permission if the attending radiation oncologist wanted to
givearadiationfractionofmorethan400rad.Tothebestof
my knowledge, he never gave it.
Following my residency, I spent 2 years at the newly
formedGrayLaboratoryinradiologyatNorthwood,aLon-
don suburb. During that time, I only carried out mouse ex-
periments, under the tutelage of Jack Fowler and the late
JulieDenekamp.Iworkedonquantifyingtheeffectsofsin-
gle and multi-fractionated radiation therapy on the blood
flow of normal kidney, liver, lung, skin, and muscle. Those
were probably the happiest years of my career, although I
didn’t appreciate it at the time.
Following this, I returned as junior faculty at Stanford
for 5 years before moving on to the National Cancer Insti-
tute for almost 15 years as the Chief of the Radiation On-
cology Branch. These were probably the most productive
years of my career. Certainly working with outstanding
people such as Vince DeVita, Steve Rosenberg, Murray
Brennan, Bob Young, Bruce Chabner, John Minna, Paul
Bunn, Dan Ihde, and Marc Lippman (to name only a few)
was very exciting and heady. During that time, I proved
very successful at both recruiting and training truly excel-
lent younger radiation oncologists, many of whom have
gone on to become chairs of academic departments. These
include such notables as Joel Tepper, Allen Lichter, Tim
Kinsella, Jim Schwade, Ted Lawrence, Drew Turrisi, Gil-
lies McKenna, Steve Hahn, and Dino Stea, again to name
only some. The turnout of such high-quality leaders of ra-
diation oncology has probably been my major accomplish-
ment. During this same period, I was able to recruit Jim
Mitchell to head our lab program. He remains a superb sci-
entist as well as a close personal friend to this day.
For the past several years my passion has largely been
photodynamic therapy for a variety of problems, but espe-
ciallytreatmentofserosalsurfacecarcinomatosis.Therere-
mains a lot of work to do yet, but I am optimistic that we
will be able eventually to take this treatment to a curative
level in the treatment of pleural and peritoneal carcinoma-
tosis, which remains palliative at this time.
It has been my very good fortune to have worked with a
verylargenumberoftrulyoutstandingpeople,onlysomeof
whom I’ve named specifically in this communication. It re-
mains my very strong belief that, if you are recruiting for a
position (any position), you need to recruit the very highest
quality person that you can possibly get. You need also to
understand that such high-quality people will virtually al-
ways receive other opportunities and they must be free to
make choices that they believe to be in their own best self-
interest, even if you believe it’s a mistake. Everyone makes
mistakes, on occasion. Just ask me!
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